BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16443620)

  • 1. Fabrication and characterization of polysulfone-dicalcium silicate composite films.
    Cheng W; Chang J
    J Biomater Appl; 2006 Apr; 20(4):361-76. PubMed ID: 16443620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds.
    Li H; Chang J
    Biomaterials; 2004 Nov; 25(24):5473-80. PubMed ID: 15142728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The self-setting properties and in vitro bioactivity of tricalcium silicate.
    Zhao W; Wang J; Zhai W; Wang Z; Chang J
    Biomaterials; 2005 Nov; 26(31):6113-21. PubMed ID: 15927252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of Poly-(DL-Lactic Acid)--Wollastonite Composite Films with Surface Modified {beta}-CaSiO3 Particles.
    Lingzhi Ye ; Jiang Chang ; Congqin Ning ; Kaili Lin
    J Biomater Appl; 2008 Mar; 22(5):465-80. PubMed ID: 17623708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term in vitro testing on the properties of bioactive glass-polysulfone composites.
    Oréfice R; West J; Latorre G; Hench L; Brennan A
    Biomacromolecules; 2010 Mar; 11(3):657-65. PubMed ID: 20108891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modification of bioactive glasses and preparation of PDLLA/bioactive glass composite films.
    Gao Y; Chang J
    J Biomater Appl; 2009 Aug; 24(2):119-38. PubMed ID: 18801895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
    Li H; Du R; Chang J
    J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
    Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
    Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive composites consisting of PEEK and calcium silicate powders.
    Kim IY; Sugino A; Kikuta K; Ohtsuki C; Cho SB
    J Biomater Appl; 2009 Aug; 24(2):105-18. PubMed ID: 18757493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
    Chouzouri G; Xanthos M
    Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium carbonate solution on self-setting properties of tricalcium silicate bone cement.
    Zhiguang Huan ; Jiang Chang
    J Biomater Appl; 2008 Nov; 23(3):247-62. PubMed ID: 18667460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.
    Lin K; Chang J; Cheng R
    Acta Biomater; 2007 Mar; 3(2):271-6. PubMed ID: 17234465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds.
    Li H; Chang J
    J Mater Sci Mater Med; 2004 Oct; 15(10):1089-95. PubMed ID: 15516869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-setting properties and in vitro bioactivity of Ca3SiO5/CaSO4.1/2H2O composite cement.
    Zhao W; Chang J; Zhai W
    J Biomed Mater Res A; 2008 May; 85(2):336-44. PubMed ID: 17688248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Ca3SiO5/CaCl2 composite cement for dental application.
    Wang X; Sun H; Chang J
    Dent Mater; 2008 Jan; 24(1):74-82. PubMed ID: 17391748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immobilization of heparin on polysulfone surface for selective adsorption of low-density lipoprotein (LDL).
    Huang XJ; Guduru D; Xu ZK; Vienken J; Groth T
    Acta Biomater; 2010 Mar; 6(3):1099-106. PubMed ID: 19733266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of bioactive calcium silicate and poly(epsilon-caprolactone) nanocomposite for bone tissue regeneration.
    Wei J; Heo SJ; Liu C; Kim DH; Kim SE; Hyun YT; Shin JW; Shin JW
    J Biomed Mater Res A; 2009 Sep; 90(3):702-12. PubMed ID: 18563819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
    Ni S; Lin K; Chang J; Chou L
    J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivity and biocompatibility of a chitosan-tobermorite composite membrane for guided tissue regeneration.
    Hurt AP; Getti G; Coleman NJ
    Int J Biol Macromol; 2014 Mar; 64():11-6. PubMed ID: 24296410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior.
    Li X; Shi J; Dong X; Zhang L; Zeng H
    J Biomed Mater Res A; 2008 Jan; 84(1):84-91. PubMed ID: 17600329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.